Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2020-02-04
1:03 pm
Sale		13GEvofem Biosciences, Inc.
EVFM		Woodford Investment Management Ltd0
0%		-3,913,274decrease
(Position Closed)		View
2020-02-04
1:01 pm
Sale		13GNightstar Therapeutics plc
NITE		Woodford Investment Management Ltd0
0%		-1,921,315decrease
(Position Closed)		View
2019-11-08
3:01 pm
Sale		13GTheravance Biopharma, Inc.
TBPH		Woodford Investment Management Ltd429,770
0.76%		-11,886,759decrease
(-96.51%)		View
2019-11-08
2:58 pm
Sale		13GEvofem Biosciences, Inc.
EVFM		Woodford Investment Management Ltd3,913,274
8.3%		-8,582,948decrease
(-68.68%)		View
2019-10-09
12:28 pm
Sale		13GAutolus Therapeutics plc
AUTL		Woodford Investment Management Ltd2,095,127
4.7%		-8,518,751decrease
(-80.26%)		View
2019-09-09
4:33 pm
Sale		13GProthena Corporation plc
PRTA		Woodford Investment Management Ltd0
0%		-8,773,790decrease
(Position Closed)		View
2019-09-09
4:23 pm
Sale		13GNuCana plc
NCNA		Woodford Investment Management Ltd1,538,000
4.8%		-1,692,999decrease
(-52.40%)		View
2019-08-08
3:13 pm
Sale		13GEvofem Biosciences, Inc.
EVFM		Woodford Investment Management Ltd12,496,222
26.8%		-497,770decrease
(-3.83%)		View
2019-08-08
3:10 pm
Sale		13GAutolus Therapeutics plc
AUTL		Woodford Investment Management Ltd10,613,878
23.6%		-1,311,541decrease
(-11.00%)		View
2019-07-09
2:59 pm
Sale		13GProthena Corporation plc
PRTA		Woodford Investment Management Ltd8,773,790
22%		-3,150,824decrease
(-26.42%)		View
2019-05-10
11:52 am
Purchase		13GEvofem Biosciences, Inc.
EVFM		Woodford Investment Management Ltd12,993,992
35.3%		975,264increase
(+8.11%)		View
2019-04-15
11:47 am
Purchase		13GNuCana plc
NCNA		Woodford Investment Management Ltd3,230,999
10%		1,365,999increase
(+73.24%)		View
2019-02-14
3:48 pm
Purchase		13GNuCana plc
NCNA		Woodford Investment Management Ltd1,865,000
5.8%		1,865,000increase
(New Position)		View
2019-02-14
3:45 pm
Purchase		13GNightstar Therapeutics plc
NITE		Woodford Investment Management Ltd1,921,315
5.8%		1,921,315increase
(New Position)		View
2019-02-14
3:37 pm
Purchase		13GProthena Corporation plc
PRTA		Woodford Investment Management Ltd11,924,614
29.9%		396,000increase
(+3.43%)		View
2019-02-14
3:34 pm
Purchase		13GTheravance Biopharma, Inc.
TBPH		Woodford Investment Management Ltd12,316,529
22.2%		1,569,421increase
(+14.60%)		View
2019-02-14
3:18 pm
Unchanged		13GNorthwest Biotherapeutics, Inc.
NWBO		Woodford Investment Management Ltd24,815,028
4.8%		0
(Unchanged)		View
2019-01-10
12:11 pm
Purchase		13GAutolus Therapeutics plc
AUTL		Woodford Investment Management Ltd11,925,419
29.7%		2,261,417increase
(+23.40%)		View
2018-12-10
2:40 pm
Purchase		13GEvofem Biosciences, Inc.
EVFM		Woodford Investment Management Ltd12,018,728
42.5%		1,999,999increase
(+19.96%)		View